吉非替尼
癌症研究
活力测定
流式细胞术
转染
肺癌
生物
细胞培养
小RNA
细胞周期
细胞
分子生物学
细胞生长
细胞凋亡
下调和上调
报告基因
免疫印迹
核糖核酸
化学
逆转录聚合酶链式反应
转录因子
竞争性内源性RNA
非翻译区
信使核糖核酸
基因表达
小干扰RNA
实时聚合酶链反应
癌症
污渍
癌细胞
MTT法
基因
作者
Xin Yu,Xueyan Fu,Xia Zhang,Changcai Bai,Yang Wang
出处
期刊:Anti-Cancer Drugs
[Lippincott Williams & Wilkins]
日期:2021-10-22
卷期号:33 (2): 158-166
被引量:14
标识
DOI:10.1097/cad.0000000000001257
摘要
To investigate the function and mechanism of circular RNA circ_0001658 on gefitinib resistance of non-small cell lung cancer (NSCLC) cells. Circ_0001658, microRNA (miRNA, miR)-409-3p and twist family bHLH transcription factor 1 (TWIST1) expression levels in NSCLC tissues and cell lines were probed by quantitative real-time PCR and Western blot assays. Cell counting kit-8 assay was adopted to examine the inhibitory effect of different concentrations of gefitinib on the viability of NSCLC cells, with the 50% concentration of inhibition (IC50) value calculated. Besides, BrdU assay and flow cytometry assay were used to detect the proliferative and apoptotic rate of NSCLC cells. What's more, the binding relationships between miR-409-3p and circ_0001658, miR-409-3p and TWIST1 mRNA 3' untranslated region (3' UTR) were confirmed by dual-luciferase reporter gene assay and RNA immunoprecipitation assay. Circ_0001658 expression was raised in NSCLC tissue samples and cell lines, which was significantly associated with TNM stage and the differentiation degree of NSCLC tissues. Knocking down circ_0001658 could restrain the viability of NSCLC cells, promote the apoptosis, and reduce the IC50 of gefitinib, while transfection of miR-409-3p inhibitors could partially reverse these impacts. Additionally, circ_0001658 directly targeted miR-409-3p and negatively modulated its expression. TWIST1 was the target of miR-409-3p, which could be indirectly and positively modulated by circ_0001658. Moreover, circ_0001658 expression was negatively interrelated with miR-409-3p expression, while positively correlated with TWIST1 expression in NSCLC samples. Circ_0001658 promotes the malignant phenotypes and the resistance to gefitinib of NSCLC cells by regulating the miR-409-3p/TWIST1 axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI